First Pradaxa Lawsuits Have Now Been Filed

News reports and government reports have now confirmed that in the first year of Pradaxa’s approved use in the United States, at least 260 patients have died from bleeding events where Pradaxa blocked the body’s natural blood clotting defense. Three of those patients have now filed Pradaxa product liability lawsuits in federal courts. These Pradaxa lawsuits, filed by a law firm not affiliated with Powers Taylor, mark the start of what will most assuredly be a landslide of similar lawsuits. If Pradaxa’s continues to be prescribed in the same numbers, and if these serious and fatal injuries continue at the same rate, Powers Taylor expects that the number of lawsuits will grow exponentially. If enough federal lawsuits are filed, the federal judiciary may transfer all such cases to a single judge, who will decide the issues common to all Praxada lawsuits, much like a class action proceeding. The initial Pradaxa cases were filed in Louisiana, Kentucky, and Tennessee. Powers Taylor has not yet determined where it will file Pradaxa claims.
Despite the frightening number of adverse events reported both in the United States and abroad, the drug’s manufacturer, Boehringer Ingelheim, has done little to react to these problems. The company supplemented its warnings in January 2012, but it has still not adopted a “black box” warning for the blood clotting problem. Medical professionals recognize the black box warnings as the most serious type of information on side effects, one that should never be ignored. Without a black box warning, there is a strong possibility that many patients and prescribing doctors will not recognize the full extent of the risks associated with Pradaxa. The absence of this warning will be the central claim — an “inadequate warning” claim — in Pradaxa lawsuits.

The side-effect lawyers at Powers Taylor are now evaluating potential Pradaxa cases. If you or a loved one took Pradaxa, and then suffered a bleeding event that required medical attention, you may have a potential claim. Many such “bleeding events” involve gastrointestinal bleeding, caused by stomach ulcers or other medical problems that might have been non-life threatening in the absence of Pradaxa. Because Pradaxa blocks the body’s natural “coagulation cascade” that leads to the formation of blood clots, an ordinary stomach ulcer can turn into a serious medical problem. Because there is no readily available anecdote for Pradaxa’s blood thinning effects, some of these routine blood loss events can become fatal. If you or a loved one have been prescribed Pradaxa and are conce
ed about these reports of adverse events, consult with the prescribing doctor before stopping the use of Pradaxa, as it may be necessary to take medical precautions to avoid other serious medical problems that could result from the sudden stoppage of Pradaxa.

To start work on your case, our product liability lawyers will need to know when the patient started using Pradaxa, the dosage prescribed, and the date of the adverse blood-loss event. Our atto
eys will also need to know whether the patient was a participant in any of the Pradaxa studies, and whether the prescribing physician ever disclosed the risk of bleeding out. Please contact us immediately if you have experienced bleeding problems after taking Pradaxa. We look forward to bringing our experience in side-effect lawsuits on unsafe drugs to your case.
For More Information Visit: http://www.unsafedrugs.com/3637/pradaxa-lawsuits-filed